In summary, betaine treatment reversed several biochemical abnormalities in the hepatic insulin signaling cascade related to glucose disposition in the liver of HF mice, beginning with increased activation of IRS1, and including increased activation of Akt and GSK3β, and increased glycogen content. The gene discussed is AKT1; the disease is hydrops fetalis.